Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014
Filters: Author is Barlow, William E [Clear All Filters]
Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer.. Patient education and counseling. 91(3):364-71.. 2013.
Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.. 2014.
Does surgeon case volume influence nonfatal adverse outcomes after rectal cancer resection? Journal of the American College of Surgeons. 206(3):1167-77.. 2008.
A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.. Clinical breast cancer. 8(6):511-5.. 2008.
Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(27):4449-57.. 2008.
A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102.. Breast cancer research and treatment. 143(2):351-8.. 2014.
Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.. The American journal of pathology. 176(4):1639-47.. 2010.
Promoting Quality and Evidence-Based Care in Early-Stage Breast Cancer Follow-up.. Journal of the National Cancer Institute.. 2014.
Measuring the performance of markers for guiding treatment decisions.. Annals of internal medicine. 154(4):253-9.. 2011.
Combination anastrozole and fulvestrant in metastatic breast cancer.. The New England journal of medicine. 367(5):435-44.. 2012.
Contrasting two frameworks for ROC analysis of ordinal ratings.. Medical decision making : an international journal of the Society for Medical Decision Making. 30(4):484-98.. 2010.
Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.. Cancer causes & control : CCC. 22(3):399-405.. 2011.
Breast Density, Body Mass Index, and Risk of Tumor Marker-Defined Subtypes of Breast Cancer.. Annals of epidemiology. 22(5):340-348.. 2012.
Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk.. Breast cancer research and treatment. 126(3):671-8.. 2011.
Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(6):1643-54.. 2010.
Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy.. Breast cancer research and treatment.. 2014.
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(24):3881-6.. 2009.
Comparison of Survival Outcomes Among Cancer Patients Treated In and Out of Clinical Trials.. Journal of the National Cancer Institute.. 2014.
Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors.. Journal of clinical & experimental dermatology research. 2(6). 2011.
Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors.. Breast cancer research and treatment. 143(3):541-50.. 2014.
Frequent antibiotic use and second breast cancer events.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(9):1588-99.. 2013.
The value of comparative effectiveness research: Projected return on investment of the RxPONDER trial (SWOG S1007).. Contemporary clinical trials. 33(6):1117-23.. 2012.
Doing Business with Arnold Library
Weintraub Building, B1-010
More About Arnold Library
- Information for Grant Writers
- Arnold Library News
- Affiliations and Memberships
- Journals List
- Web of Science - Science Citation Index
- Pubmed (Get Article Enabled)
- Library Catalog
- Document Delivery Form
- Center-Authored Papers
- Institutional Repository
- Researcher Profiles